Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
138,100
Employees138,100
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
138,100
Employees138,100

JNJ Key Statistics

Market cap
373.57B
Market cap373.57B
Price-Earnings ratio
17.25
Price-Earnings ratio17.25
Dividend yield
3.23%
Dividend yield3.23%
Average volume
6.47M
Average volume6.47M
High today
$154.66
High today$154.66
Low today
$154.55
Low today$154.55
Open price
$156.30
Open price$156.30
Volume
7.89K
Volume7.89K
52 Week high
$169.99
52 Week high$169.99
52 Week low
$140.68
52 Week low$140.68

JNJ News

Simply Wall St 3d
Johnson & Johnson Unveils Promising CAR T-Cell Therapy for B-Cell Lymphoma

recently announced promising Phase 1b study results for its CAR T-cell therapy, JNJ-90014496, indicating potential efficacy in treating large B-cell lymphoma. D...

Johnson & Johnson Unveils Promising CAR T-Cell Therapy for B-Cell Lymphoma

Analyst ratings

56%

of 25 ratings
Buy
44%
Hold
56%
Sell
0%

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.